Literature DB >> 11228300

Totally necrotic choroidal and ciliary body melanomas: associations with prognosis, episcleritis, and scleritis.

A Moshari1, E W Cheeseman, I W McLean.   

Abstract

PURPOSE: To report associations between prognosis, total tumor necrosis, scleritis, and episcleritis in choroidal and ciliary body melanomas.
METHODS: In this retrospective observational histopathologic study, 157 totally necrotic melanomas and 177 melanomas that were not totally necrotic of choroidal and ciliary body were retrieved from the Registry of Ophthalmic Pathology. The eyes were examined for the histologic evidence of inflammatory cells within the sclera and episcleral tissues. Contingency table, Kaplan-Meier, and Cox proportional hazard regression analyses were performed. In the survival analyses, only deaths with metastatic melanoma were considered as events in the statistical analysis.
RESULTS: Among the totally necrotic melanomas, 118 of 157 (75.1%) had both episcleritis and scleritis; two of 157 (1.3%) had scleritis only; 29 of 157 (18.5%) had episcleritis only; and eight of 157 (5.1%) had neither episcleritis nor scleritis. Among the non-necrotic melanomas, 23 of 177 (12.9%) had both episcleritis and scleritis; eight of 177 (4.5%) had scleritis only; 71 of 177 (40.1%) had episcleritis only; and 75 of 177 (42.3%) had neither episcleritis nor scleritis. Cox regression indicated that total necrosis and scleritis were prognostically significant (P <.05) when analyzed univariately but not significant when analyzed multivariately with tumor size.
CONCLUSIONS: Scleritis and episcleritis were statistically significantly associated with total tumor necrosis. There was a higher incidence of episcleritis than scleritis in both the necrotic and non-necrotic tumor types. Associations with patient outcome were identified for necrosis and scleritis. However, these associations were statistically insignificant when the prognostic effect of tumor size was also considered in a multivariate model.

Entities:  

Mesh:

Year:  2001        PMID: 11228300     DOI: 10.1016/s0002-9394(00)00783-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Finding malignant change in a necrotic choroidal melanocytoma: a clinical challenge.

Authors:  M Kurli; P T Finger; T Manor; S A McCormick; H E Grossniklaus
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Necrotic melanocytoma associated with polycystic liver disease and cutaneous neurofribomata.

Authors:  E M Ackuaku-Dogbe; G Osei-Kontoh; A M Alford
Journal:  J West Afr Coll Surg       Date:  2013 Oct-Dec

3.  Uveal Melanoma Mimicking Advanced Coats' Disease in a Young Patient.

Authors:  Naina Gupta; William Terrell; Lynn Schoenfield; Claudia Kirsch; Colleen M Cebulla
Journal:  Ocul Oncol Pathol       Date:  2015-11-20

Review 4.  Diagnostic vitrectomy for infectious uveitis.

Authors:  Abdallah Jeroudi; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2014

5.  Spontaneous Necrosis of Choroidal Melanoma.

Authors:  Shalini Thareja; Alia Rashid; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2014-09-10

6.  Spontaneous Necrosis of a Large Choroidal Melanoma: Unusual Presentation in a 49-Year-Old Male.

Authors:  Carmen Baumann; Danilo Iannetta; Sarah E Coupland; Carl Groenewald; Mandagere Vishwanath; Heinrich Heimann
Journal:  Ocul Oncol Pathol       Date:  2019-12-05

Review 7.  Intraocular Biopsy and ImmunoMolecular Pathology for "Unmasking" Intraocular Inflammatory Diseases.

Authors:  Rodolfo Mastropasqua; Emma Di Carlo; Carlo Sorrentino; Cesare Mariotti; Lyndon da Cruz
Journal:  J Clin Med       Date:  2019-10-19       Impact factor: 4.241

8.  Posterior Scleritis Simulating Choroidal Melanoma: A Case Report.

Authors:  Simanta Khadka; Raghunandan Byanju; Sangita Pradhan
Journal:  Beyoglu Eye J       Date:  2021-06-08

9.  Histopathologic and MR Imaging Appearance of Spontaneous and Radiation-Induced Necrosis in Uveal Melanomas: Initial Results.

Authors:  Pietro Valerio Foti; Corrado Inì; Giuseppe Broggi; Renato Farina; Stefano Palmucci; Corrado Spatola; Rocco Luca Emanuele Liardo; Roberto Milazzotto; Luigi Raffaele; Vincenzo Salamone; Rosario Caltabiano; Lidia Puzzo; Andrea Russo; Michele Reibaldi; Antonio Longo; Paolo Vigneri; Massimo Venturini; Francesco Giurazza; Teresio Avitabile; Antonio Basile
Journal:  Cancers (Basel)       Date:  2022-01-02       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.